Global healthcare M&A delivers strong performance

Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 - Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022, despite a general slowdown in M&A across the board....
By: White & Case LLP